Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress

International Immunopharmacology

Volumn 11, Issue 1, 2011, Pages 121-127

  Qiao, Ying ^a,b   Bai, Xue Fang ^a   Du, Yu Guang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Chitosan oligosaccharides; Lipid peroxidation; Lipopolysaccharide; Sepsis; TNF

Indexed keywords

CATALASE; CHITOSAN; CYTOKINE; GLUTATHIONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOSACCHARIDE; PROTEIN C JUN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE;

ANIMALS; CATALASE; CHITOSAN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; KIDNEY; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; OLIGOSACCHARIDES; OXIDATIVE STRESS; SEPSIS; SURVIVAL ANALYSIS;

EID: 78651429880     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.10.016     Document Type: Article

References (43)

1. J.-L. Vincent, Q. Sun, and M.-J. Dubois Clinical trials of immunomodulatory therapies in severe sepsis and septic shock Clin Infect Dis 34 2002 1084 1093
2. E. Lappin, and A.J. Ferguson Gram-positive toxic shock syndromes Lancet Infect Dis 9 2009 281 290
3. S.P. LaRosa, and S.M. Opal Sepsis strategies in development Clin Chest Med 29 2008 735 747
4. S.L. Orlicek Cytokine inhibitors for sepsis and septic shock Semin Pediatr Infect Dis 12 2001 24 29
5. S. Rinaldi, F. Landucci, and A.R. De Gaudio Antioxidant therapy in critically septic patients Curr Drug Targets 10 2009 872 880
6. D.A. Lowes, B.M.V. Thottakam, N.R. Webster, M.P. Murphy, and H.F. Galley The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis Free Radic Biol Med 45 2008 1559 1565
7. P.H. Zapelini, G.T. Rezin, M.R. Cardoso, C. Ritter, F. Klamt, and J.C.F. Moreira Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model Mitochondrion 8 2008 211 218
8. A.C. Kalil, J.E. Sevransky, D.E. Myers, C. Esposito, R.W. Vandivier, and P. Eichacker Preclinical trial of l-arginine monotherapy alone or with N-acetylcysteine in septic shock Crit Care Med 34 2006 2719 2728
9. H. Wu, Z. Yao, X. Bai, Y. Du, and B. Lin Anti-angiogenic activities of chitooligosaccharides Carbohydr Polym 73 2008 105 110
10. K.-T. Shen, M.H. Chen, H.-Y. Chan, J.-H. Jeng, and Y.-J. Wang Inhibitory effects of chitooligosaccharides on tumor growth and metastasis Food Chem Toxicol 47 2009 1864 1871
11. H.K. No, N.Y. Park, S.H. Lee, H.J. Hwang, and S.P. Meyers Antibacterial activities of chitosans and chitosan oligomers with different molecular weights on spoilage bacteria isolated from tofu J Food Sci 67 2002 1511 1514
12. J. Xu, X. Zhao, X. Han, and Y. Du Antifungal activity of oligochitosan against Phytophthora capsici and other plant pathogenic fungi in vitro Pesticide Biochem Physiol 87 2007 220 228
13. R.A.A. Muzzarelli Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone Carbohydr Polym 76 2009 167 182
14. T. Minagawa, Y. Okamura, Y. Shigemasa, S. Minami, and Y. Okamoto Effects of molecular weight and deacetylation degree of chitin/chitosan on wound healing Carbohydr Polym 67 2007 640 644
15. P.-J. Park, J.-Y. Je, and S.-K. Kim Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry J Agric Food Chem 51 2003 4624 4627
16. H.-T. Liu, W.-M. Li, G. Xu, X.-Y. Li, X.-F. Bai, and P. Wei Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells Pharmacol Res 59 2009 167 175
17. H.J. Yoon, M.E. Moon, H.S. Park, S.Y. Im, and Y.H. Kim Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells Biochem Biophys Res Commun 358 2007 954 959
18. J.J. Baldassare, Y.H. Bi, and C.J. Bellone The role of p38 mitogen-activated protein kinase in IL-1 beta transcription J Immunol 162 1999 5367 5373
19. J.F. Schindler, J.B. Monahan, and W.G. Smith p38 pathway kinases as anti-inflammatory drug targets J Dent Res 86 2007 800 811
20. J. Shan, J. Fu, Z. Zhao, X. Kong, H. Huang, and L. Luo Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-[kappa]B and JNK/AP-1 activation Int Immunopharmacol 9 2009 1042 1048
21. H.T. Liu, W.M. Li, X.Y. Li, Q.S. Xu, Q.S. Liu, and X.F. Bai Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide- induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases Basic Clin Pharmacol Toxicol 106 2009 362 371
22. Y. Koyama, M. Motobu, K. Hikosaka, M. Yamada, K. Nakamura, and H. Saido-Sakanaka Protective effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on endotoxic shock in mice Int Immunopharmacol 6 2006 234 240 (Pubitemid 43052820)
23. J. Dou, C. Tan, Y. Du, X. Bai, K. Wang, and X. Ma Effects of chitooligosaccharides on rabbit neutrophils in vitro Carbohydr Polym 69 2007 209 213
24. M. Torres, and H.J. Forman Redox signaling and the MAP kinase pathways Biofactors 17 2003 287 296
25. J.J. Haddad, and S.C. Land Redox/ROS regulation of lipopolysaccharide- induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis Br J Pharmacol 135 2002 520 536
26. L.N. Lopez-Bojorquez, A.Z. Dehesa, and G. Reyes-Teran Molecular mechanisms involved in the pathogenesis of septic shock Arch Med Res 35 2004 465 479
27. J.-D. Ren, J.-S. Gu, H.-F. Gao, P.-Y. Xia, and G.-X. Xiao A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo Int Immunopharmacol 8 2008 775 781
28. M. Meisner, J. Schmidt, M. Schywalsky, and K. Tschaikowsky Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock Int J Immunopharmacol 22 2000 83 90
29. G. Singer, J. Houghton, C.A. Rivera, C. Anthoni, and D.N. Granger Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice J Hepatol 47 2007 799 806
30. K. Aoshiba, S. Onizawa, T. Tsuji, and A. Nagai Therapeutic effects of erythropoietin in murine models of endotoxin shock Crit Care Med 37 2009 889 898
31. T.-C. Chou, E. Fu, and E.C. Shen Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages Biochem Biophys Res Commun 308 2003 403 407
32. M.-S. Kim, M.-J. Sung, S.-B. Seo, S.-J. Yoo, W.-K. Lim, and H.-M. Kim Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid [beta] peptide and interleukin-1[beta] Neurosci Lett 321 2002 105 109
33. H.-T. Liu, W.-M. Li, P. Huang, W.-J. Chen, Q.-S. Liu, and X.-F. Bai Chitosan oligosaccharides inhibit TNF-[alpha]-induced VCAM-1 and ICAM-1 expression in human umbilical vein endothelial cells by blocking p38 and ERK1/2 signaling pathways Carbohydr Polym 81 2010 49 56
34. O.K. Bitzer-Quintero, A.J. Davalos-Marin, G.G. Ortiz, Meza ARdA, B.M. Torres-Mendoza, and R.G. Robles Antioxidant activity of tryptophan in rats under experimental endotoxic shock Biomed Pharmacother 64 2010 77 81
35. Andrades M., Ritter C., de Oliveira M.R., Streck E.L., Fonseca Moreira J.C., Dal-Pizzol F. Antioxidant Treatment Reverses Organ Failure in Rat Model of Sepsis: Role of Antioxidant Enzymes Imbalance, Neutrophil Infiltration, and Oxidative Stress. J Surg Res. in press, doi:10.1016/j.jss.2009.08.005.
36. S. Kato, M.H. Hussein, H. Kakita, T. Goto, G.A. Daoud, and T. Kato Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis model Shock 32 2009 586 592
37. R. Kohen, and A. Nyska Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification Toxicol Pathol 30 2002 620 650
38. M.L. Urso, and P.M. Clarkson Oxidative stress, exercise, and antioxidant supplementation Toxicology 189 2003 41 54
39. Campo Giuseppe M., Avenoso Angela, Campo Salvatore, Angela D'Ascola, Traina Paola, and Samà Dario Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes J Cell Biochem 106 2009 83 92
40. G.M. Campo, A. Avenoso, S. Campo, A. D'Ascola, A.M. Ferlazzo, and A. Calatroni The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis Chem Biol Interact 148 2004 125 138
41. G.M. Campo, A. Avenoso, S. Campo, A.M. Ferlazzo, C. Micali, and L. Zanghi Hyaluronic acid and chondroitin-4-sulphate treatment reduces damage in carbon tetrachloride-induced acute rat liver injury Life Sci 74 2004 1289 1305
42. Y.H. Shon, I.K. Park, I.S. Moon, H.W. Chang, and K.S. Nam Effect of chitosan oligosaccharide on 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in mice Biol Pharm Bull 25 2002 1161 1164
43. Q. Xu, P. Ma, W. Yu, C. Tan, H. Liu, and C. Xiong Chitooligosaccharides protect human embryonic hepatocytes against oxidative stress induced by hydrogen peroxide Mar Biotechnol 12 2009 292 298